These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10887641)

  • 1. Pentostatin and rituximab in the treatment of patients with B-cell malignancies.
    Drapkin R
    Oncology (Williston Park); 2000 Jun; 14(6 Suppl 2):25-9. PubMed ID: 10887641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a phase II multicenter trial of pentostatin and rituximab in patients with low grade B-cell non-Hodgkin's lymphoma: an effective and minimally toxic regimen.
    Drapkin R; Di Bella NJ; Faragher DC; Harden E; Matei C; Hyman W; Mirabel M; Boehm KA; Asmar L
    Clin Lymphoma; 2003 Dec; 4(3):169-75. PubMed ID: 14715099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
    Kraut EH
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
    Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
    Dearden CE; Matutes E; Catovsky D
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):22-6. PubMed ID: 10877047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I and II study of pentostatin (Nipent) with cyclophosphamide for previously treated patients with chronic lymphocytic leukemia.
    Weiss MA
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):41-3. PubMed ID: 10877051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentostatin (Nipent) in the treatment of chronic lymphocyte leukemia and hairy cell leukemia.
    Dillman RO
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):27-36. PubMed ID: 14748654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
    Dennie TW; Kolesar JM
    Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-based phase II trial of PCR for CLL/SLL patients.
    Kay NE; Shanafelt TD; Byrd JC; Grever MR
    Cancer Biother Radiopharm; 2007 Oct; 22(5):713-4; author reply 715-7. PubMed ID: 17979574
    [No Abstract]   [Full Text] [Related]  

  • 12. Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era.
    Nabhan C; Gartenhaus RB; Tallman MS
    Leuk Res; 2004 May; 28(5):429-42. PubMed ID: 15068894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with purine nucleoside analogs.
    Foss FM
    Oncology (Williston Park); 2000 Jun; 14(6 Suppl 2):31-5. PubMed ID: 10887642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of bendamustine in rituximab-refractory indolent B-cell non-Hodgkin lymphoma: review of a pivotal trial.
    Ujjani C; Cheson B
    Future Oncol; 2011 Jan; 7(1):9-14. PubMed ID: 21174533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentostatin treatment combinations in chronic lymphocytic leukemia.
    Lamanna N; Kay NE
    Clin Adv Hematol Oncol; 2009 Jun; 7(6):386-92. PubMed ID: 19606074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious complications of pentostatin therapy.
    Vose JM; Cabanillas F; O'Brien S; Dang N; Drapkin R; Foss F
    Oncology (Williston Park); 2000 Jun; 14(6 Suppl 2):41-2. PubMed ID: 10887644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-based phase II trial of pentostatin, cyclophosphamide, and rituximab (PCR) biochemotherapy in chronic lymphocytic leukemia and small lymphocytic lymphoma.
    Dillman RO; Schreeder MT; Hon JK; Connelly EF; DePriest C; Cutter K
    Cancer Biother Radiopharm; 2007 Apr; 22(2):185-93. PubMed ID: 17600465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of resistant/relapsing chronic lymphocytic leukemia with a combination regimen containing deoxycoformycin and rituximab.
    Tsiara SN; Kapsali HD; Chaidos A; Christou L; Bourantas KL
    Acta Haematol; 2004; 111(4):185-8. PubMed ID: 15153709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Cvetković RS; Perry CM
    Drugs; 2006; 66(6):791-820. PubMed ID: 16706552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
    Willis CR; Goodrich A; Park K; Waselenko JK; Lucas M; Reese A; Diehl LF; Grever MR; Byrd JC; Flinn IW
    Ann Hematol; 2006 May; 85(5):301-7. PubMed ID: 16518606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.